Breast Neoplasms - Pathology
Research News and Information

Saturday, November 21, 2009

HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.

29 Nov 2009 HER3 (ERBB3) is a catalytically inactive pseudokinase of the HER receptor tyrosine kinase family, frequently overexpressed in prostate and other cancers. Aberrant expression and mutations of 2 other members of the family, EGFR and HER2, are key ... Read more...

Mitotic index of invasive breast carcinoma. Achieving clinically meaningful precision and evaluating tertial cutoffs.

30 Oct 2009 CONTEXT: Mitotic figure counts are related to breast cancer behavior but have not been sufficiently reproducible to be accepted for clinical decision-making. OBJECTIVE: To improve reproducibility and accuracy of the mitotic count. DESIGN: Mitotic ... Read more...

Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.

30 Oct 2009 Apocrine metaplasia is a ubiquitous component of the mammary fibrocystic change spectrum. Although mostly associated with cysts, apocrine metaplasia can also present as a proliferative lesion, rarely with cytologic atypism. Apocrine atypia is ... Read more...

Latest indexed articles for 'Breast Neoplasms - Pathology'

These are the very latest articles for this heading:

• HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells. 29 Nov 2009
• Mitotic index of invasive breast carcinoma. Achieving clinically meaningful precision and evaluating tertial cutoffs. 30 Oct 2009
• Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case. 30 Oct 2009
• Should pathologists send all or only selected slides for patient-requested interlaboratory second opinion? 30 Oct 2009
• Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. 30 Oct 2009
• Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. 30 Oct 2009
• Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ. 30 Oct 2009
• Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. 30 Oct 2009
• Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. 30 Oct 2009
• EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer. 30 Oct 2009
• Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. 16 Oct 2009
• Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system. 13 Oct 2009
• Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. 13 Oct 2009
• FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. 13 Oct 2009
• Parity and age at first childbirth in relation to the risk of different breast cancer subgroups. 13 Oct 2009
• TOB suppresses breast cancer tumorigenesis. 13 Oct 2009
• Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications. 6 Oct 2009
• Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. 6 Oct 2009
• Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer. 4 Oct 2009
• Immediate reconstruction with an expander/implant following ablatio mammae because of breast cancer : side effects and cosmetic results after adjuvant chest wall radiotherapy. 4 Oct 2009

See a longer list of these articles.

Technical information about 'Breast Neoplasms'

Definition: Tumors or cancer of the human BREAST.

Descriptor UI: D001943

Alternative terms: Breast Neoplasms; Breast Neoplasm; Neoplasm, Breast; Neoplasms, Breast; Tumors, Breast; Breast Tumors; Breast Tumor; Tumor, Breast; Mammary Carcinoma, Human; Carcinoma, Human Mammary; Carcinomas, Human Mammary; Human Mammary Carcinomas; Mammary Carcinomas, Human; Human Mammary Carcinoma; Mammary Neoplasms, Human; Human Mammary Neoplasm; Human Mammary Neoplasms; Neoplasm, Human Mammary; Neoplasms, Human Mammary; Mammary Neoplasm, Human; Breast Cancer; Cancer, Breast; Cancer of the Breast; Cancer of Breast;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.180; C17.800.090.500;

Technical Notes: human only; BREAST NEOPLASMS, MALE is also available; for animal use MAMMARY NEOPLASMS, ANIMAL or MAMMARY NEOPLASMS, EXPERIMENTAL: Manual 24.5+, 24.6+; coordinate IM with histological type of neoplasm (IM)